Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) Tax Provisions: 2018-2024

Historic Tax Provisions for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to $3.3 million.

  • Pharming Group N.V's Tax Provisions fell 286.51% to -$5.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$2.3 million, marking a year-over-year decrease of 167.96%. This contributed to the annual value of $3.3 million for FY2024, which is 328.76% up from last year.
  • Pharming Group N.V's Tax Provisions amounted to $3.3 million in FY2024, which was up 328.76% from -$1.5 million recorded in FY2023.
  • Pharming Group N.V's 5-year Tax Provisions high stood at $7.1 million for FY2021, and its period low was -$1.5 million during FY2023.
  • Over the past 3 years, Pharming Group N.V's median Tax Provisions value was $1.3 million (recorded in 2022), while the average stood at $1.1 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 211.50% in 2023, then surged by 328.76% in 2024.
  • Pharming Group N.V's Tax Provisions (Yearly) stood at $6.3 million in 2020, then rose by 11.56% to $7.1 million in 2021, then crashed by 81.46% to $1.3 million in 2022, then tumbled by 211.50% to -$1.5 million in 2023, then surged by 328.76% to $3.3 million in 2024.